In the meantime, practitioners of this new kind of mental healthcare can use ketamine as their psychedelic agent; and some studies, such as the one Grant participated in, are even government funded. The Ketamine for Reduction of Alcoholic Relapse (Kare) study is a novel attempt to ease the huge burden on the NHS caused by alcohol-related illnesses.
Taking Ketamine And Facing My Fear of Dying Read More »
Can LSD and psilocybin provide relief to people suffering from difficult-to-treat conditions such as depression and anxiety? Robin Carhart-Harris is a neuroscientist and head of the Imperial Centre for Psychedelic Research, which builds on over a decade of pioneering work psychedelic research, including a clinical trial that has kick-started global efforts to develop psilocybin therapy into a licensed treatment for depression.
Ketamine Explained, The Next Big Antidepressant | The War on Drugs Read More »
Could the club drug, ketamine, be the best hope for curing chronic depression? Every year millions of Americans struggle with major depression, but 30% of these people don’t get any better on anti-depressants. However, low dose ketamine infusions can offer complete relief from depressive thoughts and feelings in as little as 1-2 hours.
Vice News: The Experimental Ketamine Cure For Depression Read More »
NAD+ is popular among the “anti-aging community,” thanks to a Harvard Medical School study that found it rewound “aspects of age-related demise in mice.” It’s also supposedly good for: detoxing from alcohol and drugs, increasing energy and focus, reducing chronic fatigue, increasing your metabolism, and improving your cardiovascular health.
Vice News: Does NAD+ Really Work Read More »